The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling

Trends in Biochemical Sciences

Volumn 28, Issue 6, 2003, Pages 284-293

  Neel, Benjamin G ^a   Gu, Haihua ^a   Pao, Lily ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTEGRIN; ISOPROTEIN; PHOSPHATASE; PROTEIN SRC HOMOLOGY 2; TYROSINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; CRYSTAL STRUCTURE; CYTOLOGY; GENE CONTROL; GENE DELETION; GENE MUTATION; HUMAN; INVERTEBRATE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN; VERTEBRATE;

HELICOBACTER; HELICOBACTER PYLORI; INVERTEBRATA; VERTEBRATA;

EID: 0038771965     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0004(03)00091-4     Document Type: Review

References (96)

1. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 103:2000;211-225.
2. Andersen J.N., et al. Structural and evolutionary relationships among protein tyrosine phosphatase domains. Mol. Cell. Biol. 21:2001;7117-7136.
3. Van Vactor D., et al. Genetic analysis of protein tyrosine phosphatases. Curr. Opin. Genet. Dev. 8:1998;112-126.
4. Feng G.S. Shp-2 tyrosine phosphatase: signaling one cell or many. Exp. Cell Res. 253:1999;47-54.
5. Zhang J., et al. Role of the Shp-1 tyrosine phosphatase in the negative regulation of cell signaling. Semin. Immunol. 12:2000;361-378.
6. Neel, B.G. et al. SH2 domain-containing protein tyrosine phosphatases. Handbook Cell Signaling (in press).
7. Craggs G., Kellie S. A functional nuclear localization sequence in the C-terminal domain of Shp-1. J. Biol. Chem. 276:2001;23719-23725.
8. Yang W., et al. A bipartite NLS at the SHP-1 C terminus mediates cytokine-induced SHP-1 nuclear localization in cell growth control. Blood Cells Mol. Dis. 28:2002;63-74.
9. Ravetch J.V., Lanier L.L. Immune inhibitory receptors. Science. 290:2000;84-89.
10. Beebe K.D., et al. Determination of the binding specificity of the SH2 domains of protein tyrosine phosphatase SHP-1 through the screening of a combinatorial phosphotyrosyl peptide library. Biochemistry. 39:2000;13251-13260.
11. Philosof-Oppenheimer R., et al. An immunoreceptor tyrosine-based inhibitory motif, with serine at site Y-2, binds SH2-domain-containing phosphatases. Eur. J. Biochem. 267:2000;703-711.
12. Daigle I., et al. Death receptors bind SHP-1 and block cytokine-induced anti-apoptotic signaling in neutrophils. Nat. Med. 8:2002;61-67.
13. Vely F., et al. Differential association of phosphatases with hematopoietic co-receptors bearing immunoreceptor tyrosine-based inhibition motifs. Eur. J. Immunol. 27:1997;1994-2000.
14. Schmitz J., et al. SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130. J. Biol. Chem. 275:2000;12848-12856.
15. Nicholson S.E., et al. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. Proc. Natl. Acad. Sci. U. S. A. 97:2000;6493-6498.
16. Sasaki A., et al. CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and Jak2. J. Biol. Chem. 275:2000;29338-29347.
17. Barford D., Neel B.G. Revealing mechanisms for SH2 domain-mediated regulation of the protein tyrosine phosphatase SHP-2. Structure. 6:1998;249-254.
18. Hof P., et al. Crystal structure of the SH2 domain phosphatase SHP-2. Cell. 92:1998;441-450.
19. Wang L.L., et al. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B. J. Immunol. 162:1999;1318-1323.
20. Yang J., et al. Crystal structure of the catalytic domain of protein-tyrosine phosphatase SHP-1. J. Biol. Chem. 273:1998;28199-28207.
21. O'Reilly A.M., et al. Activated mutants of SHP-2 preferentially induce elongation of Xenopus animal caps. Mol. Cell. Biol. 20:2000;299-311.
22. Lu W., et al. Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling. Mol. Cell. 8:2001;759-769.
23. Ram P.A., Waxman D.J. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase. J. Biol. Chem. 272:1997;17694-17702.
24. Meng T.-C., et al. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol. Cell. 9:2002;387-399.
25. Hamlet M.R.J., Perkins L.A. Analysis of corkscrew signaling in the Drosophila epidermal growth factor receptor pathway during myogenesis. Genetics. 159:2001;1073-1087.
26. Gutch M.J., et al. The Caenorhabditis elegans SH2 domain-containing protein tyrosine phosphatase PTP-2 participates in signal transduction during oogenesis, embryogenesis and vulval development. Genes Dev. 12:1998;571-585.
27. Schutzman J.L., et al. The Caenorhabditis elegans EGL-15 signaling pathway implicates a DOS-like multisubstrate adaptor protein in fibroblast growth factor signal transduction. Mol. Cell. Biol. 21:2001;8104-8116.
28. Saxton T., Pawson T. Morphogenetic movements at gastrulation require the SH2 tyrosine phosphatase Shp2. Proc. Natl. Acad. Sci. U. S. A. 96:1999;3790-3795.
29. Qu C.-K., et al. Biased suppression of hemtopoiesis and multiple developmental defects in chimeric mice containing SHP2 mutant cells. Mol. Cell. Biol. 18:1998;6075-6082.
30. Saxton T., et al. The SH2 tyrosine phosphatase Shp2 is required for mammalian limb development. Nat. Genet. 24:2000;420-423.
31. Roach T.I., et al. The protein tyrosine phosphatase SHP-1 regulates integrin-mediated adhesion of macrophages. Curr. Biol. 8:1998;1035-1038.
32. Kruger J., et al. Deficiency of Src homology 2-containing phosphatase 1 results in abnormalities in murine neutrophil function: studies in motheaten mice. J. Immunol. 165:2000;5847-5849.
33. Roach T., et al. CD45 regulates src family member kinase activity associated with macrophage integrin-mediated adhesion. Curr. Biol. 7:1997;408-417.
34. Timms J.F., et al. SHPS-1 is a scaffold for assembling distinct adhesion-regulated multi-protein complexes in macrophages. Curr. Biol. 9:1999;927-930.
35. Peterson E.J., et al. Coupling of the TCR to integrin activation by SLAP130/Fyb. Science. 293:2001;2263-2265.
36. Griffiths E.K., et al. Positive regulation of T cell activation and integrin adhesion by the adapter Fyb/Slap. Science. 293:2001;2260-2263.
37. Krause M., et al. Fyn-binding protein (Fub)/SLP-76-associated protein (SLAP), Ena/vasodilator-stimulated phosphoprotein (VASP) proteins and the Arp2/3 complex link T cell receptor (TCR) signaling to the actin cytoskeleton. J. Cell Biol. 149:2000;181-194.
38. Inagaki K., et al. SHPS-1 regulates integrin-mediated cytoskeletal reorganization and cell motility. EMBO J. 19:2000;6721-6731.
39. Gresham G.D., et al. Negative regulation of phagocytosis in murine macrophages by the src kinase family member, Fgr. J. Exp. Med. 191:2000;515-528.
40. Jiang P., et al. Integrin-associated protein is a ligand for the P84 neural adhesion molecule. J. Biol. Chem. 274:1999;559-562.
41. Oldenborg P.A., et al. Role of CD47 as a marker of self on red blood cells. Science. 288:2000;2051-2054.
42. Oldenborg P.-A., et al. CD47-signal regulatory protein α (SIRPα) regulates Fcγ and complement receptor-mediated phagocytosis. J. Exp. Med. 193:2001;855-861.
43. Klingmuller U., et al. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell. 80:1995;729-738.
44. Zang H., et al. The distal region and receptor tyrosines of the Epo receptor are non-essential for in vivo erythropoiesis. EMBO J. 20:2001;3156-3166.
45. Noguchi T., et al. Role of SH-PTP2, a protein-tyrosine phosphatase with src homology 2 domains, in insulin-stimulated ras activation. Mol. Cell. Biol. 14:1994;6674-6682.
46. Shi Z.Q., et al. Molecular mechanism for the Shp-2 tyrosine phosphatase function in promoting growth factor stimulation of Erk activity. Mol. Cell. Biol. 20:2000;1526-1536.
47. O'Reilly A.M., Neel B.G. Structural determinants of SHP-2 function and specificity in Xenopus mesoderm induction. Mol. Cell. Biol. 18:1998;161-177.
48. Allard J., et al. Mutational analysis of the SRC homology 2 domain protein-tyrosine phosphatase Corkscrew. J. Biol. Chem. 273:1998;13129-13135.
49. Klinghoffer R.A., Kazlauskas A. Identification of a putative Syp substrate, the PDGFB receptor. J. Biol. Chem. 270:1995;22208-22217.
50. Cleghon V., et al. Opposing actions of CSW and RasGAP modulate the strength of Torso RTK signaling in the Drosophila terminal pathway. Mol. Cell. 2:1998;719-727.
51. Pawson T., Scott J.D. Signaling through scaffold, anchoring and adapter proteins. Science. 278:1997;2075-2080.
52. Itoh M., et al. Role of Gab1 in heart, placenta and skin development and growth factor- and cytokine-induced extracellular signal-related kinase mitogen-activated protein kinase activation. Mol. Cell. Biol. 20:2000;3695-3704.
53. Sachs M., et al. Essential role of Gab1 for signaling by the c-Met receptor in vivo. J. Cell Biol. 150:2000;1375-1384.
54. Hadari Y.R., et al. Critical role for the docking-protein FRS2 alpha in FGF receptor-mediated signal transduction pathways. Proc. Natl. Acad. Sci. U. S. A. 98:2001;8578-8583.
55. Maroun C.R., et al. The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the Met receptor tyrosine kinase. Mol. Cell. Biol. 20:2000;8513-8525.
56. Schaeper U., et al. Coupling of Gab1 to c-Met, Grb2, and Shp2 mediates biological responses. J. Cell Biol. 149:2000;1419-1432.
57. Herbst R., et al. Recruitment of the protein tyrosine phosphatase CSW by DOS is an essential step during signaling by the sevenless receptor tyrosine kinase. EMBO J. 18:1999;6950-6951.
58. Bausenwein B.S., et al. In vivo functional analysis of the daughter of sevenless protein in receptor tyrosine kinase signaling. Mech. Dev. 90:2000;205-215.
59. Cunnick J.M., et al. Phosphotyrosines 627 and 659 of Gab1 constitute a bisphosphoryl tyrosine-based activation motif (BTAM) conferring binding and activation of SHP2. J. Biol. Chem. 276:2001;24380-24387.
60. Allard J.D., et al. The SH2-containing tyrosine phosphatase corkscrew is required during signaling by sevenless, Ras1 and Raf. Development. 122:1996;1137-1146.
61. Cunnick J.M., et al. Regulation of the mitogen-activated protein kinase signaling pathway by SHP2. J. Biol. Chem. 277:2002;9498-9504.
62. Su J., et al. Receptor protein tyrosine phosphatase alpha activates Src-family kinases and controls integrin-mediated responses in fibroblasts. Curr. Biol. 9:1999;505-511.
63. Ponniah S., et al. Targeted disruption of the tyrosine phosphatase PTPα leads to constitutive downregulation of the kinases Src and Fyn. Curr. Biol. 9:1999;535-538.
64. Kawabuchi M., et al. Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases. Nature. 404:2000;999-1003.
65. Bridcka T., et al. Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, bind the protein tyrosine kinase csk and is involved in regulation of T cell activation. J. Exp. Med. 191:2000;1591-1604.
66. Hacohen N., et al. Sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell. 92:1998;253-263.
67. Gross I., et al. Mammalian sprouty proteins inhibit cell growth and differentiation by preventing ras activation. J. Biol. Chem. 276:2001;46460-46468.
68. Hanafusa H., et al. Sprouty 1 and Sprouty 2 provide a control mechanism for the Ras/MapK signaling pathway. Nat. Cell Biol. 4:2002;850-858.
69. Yamauchi K., et al. Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling. Proc. Natl. Acad. Sci. U. S. A. 92:1995;664-668.
70. Hou X.S., et al. The torso receptor tyrosine kinase can activate Raf in a Ras-independent pathway. Cell. 81:1995;63-71.
71. Lorenzen J.A., et al. Nuclear import of activated D-ERK by DIM-7, an importin family member encoded by the gene moleskin. Development. 128:2001;1403-1414.
72. Gu H., et al. Cloning and characterization of the major SHP-2 binding protein in hematopoietic cells (p97) reveals a novel pathway for cytokine-induced gene activation. Mol. Cell. 2:1998;729-740.
73. Wu C.-J., et al. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors. Oncogene. 20:2001;6018-6025.
74. Zhang S.Q., et al. Receptor-specific regulation of phosphatidyl 3′-kinase activation by the protein tyrosine phosphatase Shp2. Mol. Cell. Biol. 22:2002;4062-4072.
75. Shi Z., et al. The Shp-2 tyrosine phosphatase has opposite effects in mediating the activation of extracellular signal-regulated and c-Jun NH2-terminal mitogen-activated protein kinases. J. Biol. Chem. 273:1998;4904-4908.
76. You M., et al. Modulation of the nuclear factor κ B pathway by Shp-2 tyrosine phosphatase in mediating the induction of interleukin (IL)-6 by IL-1 or tumor necrosis factor. J. Exp. Med. 193:2001;101-110.
77. Yu D.-H., et al. Protein-tyrosine phosphatase SHP-2 regulates cell spreading, migration and focal adhesion. J. Biol. Chem. 273:1998;21125-21131.
78. Oh E.-S., et al. Regulation of early events in integrin signaling by the protein-tryosine phosphatase SHP-2. Mol. Cell. Biol. 19:1999;3205-3215.
79. Inagaki K., et al. Roles for the protein tyrosine phosphatase SHP-2 in cytoskeletal organization, cell adhesion, and cell migration revealed by over-expression of a dominant negative mutant. Oncogene. 19:2000;75-84.
80. Schoenwaelder S.M., et al. The protein tyrosine phosphatase Shp-2 regulates RhoA activity. Curr. Biol. 10:2000;1523-1526.
81. Tsuda M., et al. Integrin-mediated tyrosine phosphorylation of SHPS-1 and its association with SHP-2. J. Biol. Chem. 273:1998;13223-13229.
82. Manes S., et al. Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility. Mol. Cell. Biol. 19:1999;3125-3135.
83. Miao H., et al. Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation. Nat. Cell Biol. 2:2000;62-69.
84. Tartaglia M., et al. Mutations in PTPN11, encoding protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat. Genet. 29:2001;465-468.
85. Tartaglia M., et al. Somatic PTPN11 mutations in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Blood. 100:2002;141a.
86. Kosaki K., et al. PTPN11 (Protein-Tyrosine Phosphatase, Nonreceptor type 11) mutations in seven Japanese patients with Noonan syndrome. J. Clin. Endocrinol. Metab. 87:2002;3529-3533.
87. Tartaglia M., et al. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am. J. Hum. Genet. 70:2002;1555-1563.
88. van der Burgt I., Brunner H. Genetic heterogeneity in Noonan syndrome: evidence for an autosomal recessive form. Am. J. Med. Genet. 94:2000;46-51.
89. Choong K., et al. Juvenile myelomonocytic leukemia and Noonan Syndrome. J. Pediatr. Hematol. Oncol. 21:1999;523-527.
90. Arico M., et al. Juvenile myelomonocytic leukemia. Blood. 90:1997;479-488.
91. Bos J.L. The ras gene family and human carcinogenesis. Mutat. Res. 195:1988;255-271.
92. Higashi H., et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science. 295:2002;683-686.
93. Mimuro H., et al. Grb2 is a key mediator of helicobacter CagA protein activities. Mol. Cell. 10:2002;745-755.
94. Selbach M., et al. The HelicobacterCagA protein induces cortactin dephosphorylation and actin regulation by c-Src inactivation. EMBO J. 22:2003;515-528.
95. Sattler M., et al. Critical role for Gab2 in transformation by BCR/ABL. Cancer Cell. 1:2002;479-492.
96. Daly R.J., et al. The docking protein Gab2 is overexpressed and estrogen regulated in human breast cancer. Oncogene. 21:2002;5175-5181.